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Virtually all animals have periods of inactivity or behavio-
ral quiescence, when locomotion stops. In Drosophila,
behavioral quiescence corresponds to sleep and is control-
led by some of the same genes and neurochemicals that
affect mammalian sleep, suggesting that the genetic con-
trol of quiescence is phylogenetically ancient. We provide,
for the first time, a quantitative description of behavioral
quiescence in C. elegans, a nematode. As noted by others
(Singh and Sulston '78), periods of quiescence occur dur-
ing the transitions between the four larval stages, but not
during the adult stage. We provide descriptive statistics for
the normal onset, duration, and consolidation of these
quiescent periods, as a baseline for studying mutants. We
find that the quiescence is fully reversible upon mechani-
cal stimulation, indicating that this behavioral state is
under nervous system regulation. To begin to unravel the
genetic machinery that controls quiescence, we have been
studying eat-7 (ad450sd), a C. elegans dominant mutant
that displays increased behavioral quiescence during
lethargus as well as an increase in quiescence during the
adult period. When stimulated mechanically or when
starved, eat-7 mutants move normally, suggesting that the
defect in eat-7 is not in the muscles or motor neurons. eat-
7 has the same genetic map position but opposite pheno-
types to those of mutants with loss of function of the EGL-
4 cGMP-dependent protein kinase (PKG). We found that
eat-7 mutants contain a glycine to arginine mutation in
PKG. This glycine, found in the cGMP-binding domain
closer to the kinase domain, it conserved in all cyclic
nucleotide-binding proteins, suggesting that this muta-
tion would have major consequences for enzyme func-
tion.
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